Mats Blom leaves Zealand Pharma

After nine years at the company, Mats Blom, Chief Financial Officer, will leave Zealand Pharma at the end of March 2019. Following the resignation of Britt Meelby Jensen on 26 November 2018, the Board of Directors has decided that Britt will be released from her duties as President and CEO as of 28 February 2019. … Continue reading Mats Blom leaves Zealand Pharma